Cargando…

The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study

BACKGROUND: Autoimmune thyroid disease is a common complication of patients with chronic hepatitis C undergoing combination pegylated interferon-α and ribavirin treatment. A small proportion develops interferon-induced thyroiditis of which the long term natural history is unknown and how it compares...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Huy A, Jones, Tracey L, Ianna, Elizabeth A, Reeves, Glenn EM
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022887/ https://www.ncbi.nlm.nih.gov/pubmed/21214950 http://dx.doi.org/10.1186/1756-6614-4-2

Ejemplares similares

The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon-α Therapy for Chronic Hepatitis C
por: Tran, Huy A., et al.
Publicado: (2009)

The influence of hepatitis C infection and interferon-α therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case report
por: Tran, Huy A, et al.
Publicado: (2009)

The Reduced Predictive Value of Interleukin 28b Gene Polymorphisms in a Cohort of Patients With Thyroiditis Developed During Antiviral Therapy for Chronic Hepatitis C: A Preliminary Study
por: Tran, Huy A, et al.
Publicado: (2012)

Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study
por: Tran, Huy A, et al.
Publicado: (2011)

The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin
por: Tran, Huy A, et al.
Publicado: (2005)

Exacerbation of hepatitis C induced subclinical hypoadrenalism by Interferon-alpha2beta: A case report
por: Tran, Huy A, et al.
Publicado: (2008)

The Natural History Model of Hepatitis C Virus Infection and the Economic Evaluation of Alpha Interferon Treatment
por: Hayashida, Kenshi, et al.
Publicado: (2007)

Thyroid dysfunction is associated with the loss of hepatitis B surface antigen in patients with chronic hepatitis B undergoing treatment with α-interferon
por: Luo, Wenfan, et al.
Publicado: (2021)

Human natural interferon-α producing cells
por: Fitzgerald-Bocarsly, Patricia
Publicado: (1993)

Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive Factors
por: Yan, Zehui, et al.
Publicado: (2012)

Long-term pegylated interferon-α and its potential in the treatment of melanoma
por: Dummer, Reinhard, et al.
Publicado: (2009)

The Natural History and Management of Hepatic Hemangioma
por: Maruyama, Shigeo, et al.
Publicado: (2023)

Distinct Features in Natural History and Outcomes of Acute Hepatitis C
por: Bunchorntavakul, Chalermrat, et al.
Publicado: (2015)

STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α
por: Yamauchi, Shota, et al.
Publicado: (2016)

A study of the natural history of "hot" thyroid nodules.
por: Landgarten, S., et al.
Publicado: (1973)

The paradox of NKp46(+) natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment
por: Pembroke, Tom, et al.
Publicado: (2014)

Adolescent idiopathic scoliosis: natural history and long term treatment effects
por: Asher, Marc A, et al.
Publicado: (2006)

Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan
por: Chang, Yu-Kang, et al.
Publicado: (2019)

Thyroid Dysfunction in Non-Interferon Treated Hepatitis C Patients Residing in Hepatitis Endemic Area
por: Batool, Nayab, et al.
Publicado: (2017)

Congenital myasthenic syndromes: Natural history and long-term prognosis
por: Jagtap, Sujit Abajirao, et al.
Publicado: (2013)

Hepatic Sarcoidosis: Natural History and Management Implications
por: Sedki, Mai, et al.
Publicado: (2019)

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2011)

Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy
por: Jadali, Zohreh
Publicado: (2013)

Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan
por: Shafiq, Muhammad Imtiaz, et al.
Publicado: (2015)

Long-Term Follow-Up of Acute Hepatitis B: New Insights in Its Natural History and Implications for Antiviral Treatment
por: Menzo, Stefano, et al.
Publicado: (2018)

EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms
por: Cassiman, David, et al.
Publicado: (2022)

Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia
por: Sato, Akira, et al.
Publicado: (2014)

Exogenous Interferon-α and Interferon-γ Increase Lethality of Murine Inhalational Anthrax
por: Gold, Jeffrey A., et al.
Publicado: (2007)

Pernio and early SARS‐CoV‐2 variants: natural history of a prospective cohort and the role of interferon
por: Ng, Ashley T., et al.
Publicado: (2022)

Vitamin D Levels Are Associated with Expression of SLE, but Not Flare Frequency
por: Squance, Marline L., et al.
Publicado: (2014)

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma
por: Kesby, Nicholas, et al.
Publicado: (2023)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
por: Rashed, Yasser K., et al.
Publicado: (2020)

Age-related increase of porcine natural interferon α producing cell frequency and of interferon yield per cell
por: Nowacki, W., et al.
Publicado: (1993)

Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2010)

Prevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy
por: Goyal, Gitanjali, et al.
Publicado: (2016)

Long-term Pegylated Interferon-α-2a Treatment for Chronic Hepatitis C in an Elderly Renal Transplant Recipient: Case Report and Literature Review
por: Zheng, Ming-Hua, et al.
Publicado: (2015)

Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy
por: Yoshida, Kanako, et al.
Publicado: (2021)

The Natural History of Hepatitis C Virus (HCV) Infection
por: Chen, Stephen L., et al.
Publicado: (2006)

Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity
por: Kadowaki, Norimitsu, et al.
Publicado: (2000)

Risk factors for the development of depression in patients with hepatitis C taking interferon-α
por: Smith, Kimberley J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fijhq72oldkbbrvqkga9s8ku80